Cargando…

A Study on Weight Loss Cause as per the Side Effect of Liraglutide

PURPOSE: Liraglutide is known to have much lower weight loss effects in real clinical fields than in randomized clinical trials because of its side effects (SE) and discomfort associated with injections. This study is aimed at determining whether the side effects of liraglutide affect weight reducti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jin, Lee, Jeongmin, Lee, Seung-Hwan, Cho, Jae-Hyung, Kim, Hun-Sung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733986/ https://www.ncbi.nlm.nih.gov/pubmed/36540096 http://dx.doi.org/10.1155/2022/5201684

Ejemplares similares

Clinical effectiveness of liraglutide on weight loss in South Koreans: First real-world retrospective data on Saxenda in Asia
por: Park, Joon Seok, et al.
Publicado: (2021)

The efficacy of liraglutide combined with intragastric balloon on weight loss
por: Yilmaz, Ahmet, et al.
Publicado: (2023)

The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study
por: Rasmussen, Christina B., et al.
Publicado: (2014)

The potent synergistic effects of the combination of liraglutide and canagliflozin on glycemic control and weight loss
por: Bell, David S.H.
Publicado: (2014)

Side Effects Associated with Liraglutide Treatment for Obesity as Well as Diabetes
por: Seo, Young-Gyun
Publicado: (2021)

Early Weight Loss with Liraglutide 3.0 mg Predicts 1‐Year Weight Loss and is Associated with Improvements in Clinical Markers
por: Fujioka, Ken, et al.
Publicado: (2016)

Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes
por: Hansen, Christian Stevns, et al.
Publicado: (2019)

The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery
por: Colbourne, James R. M., et al.
Publicado: (2023)

Liraglutide and DPP-4 inhibitors – side effects comparative clinical study
por: TIMOFTE, LUMINIŢA, et al.
Publicado: (2013)

Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post‐bariatric surgery
por: Wharton, Sean, et al.
Publicado: (2019)

Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery
por: Muratori, Fabrizio, et al.
Publicado: (2022)

GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice
por: Frikke-Schmidt, Henriette, et al.
Publicado: (2019)

Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review
por: Xie, Zeyu, et al.
Publicado: (2022)

Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real‐world effectiveness study in Canada
por: Wharton, Sean, et al.
Publicado: (2020)

Clinical and Genetic Predictors of Glycemic Control and Weight Loss Response to Liraglutide in Patients with Type 2 Diabetes
por: Kyriakidou, Artemis, et al.
Publicado: (2022)

Liraglutide for weight management: a critical review of the evidence
por: Mehta, A., et al.
Publicado: (2016)

Factors associated with gastrointestinal side effects after liraglutide treatment for type 2 diabetes
por: Wu, Hao, et al.
Publicado: (2023)

Differences in Clinical Outcomes between Patients with and without Hypoglycemia during Hospitalization: A Retrospective Study Using Real-World Evidence
por: Lee, Jeongmin, et al.
Publicado: (2020)

Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome
por: Kim, Yoo-Mi, et al.
Publicado: (2020)

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
por: Lean, M E J, et al.
Publicado: (2014)

Subcutaneous adipose tissue composition and function are unaffected by liraglutide‐induced weight loss in adults with type 1 diabetes
por: Wegeberg, Anne‐Marie, et al.
Publicado: (2021)

Marked weight loss on liraglutide 3.0 mg: Real‐life experience of a Swiss cohort with obesity
por: Santini, Sara, et al.
Publicado: (2022)

Mid-term Outcomes of Side-to-Side Stapled Anastomosis in Cervical Esophagogastrostomy
por: Jo, Won-Min, et al.
Publicado: (2006)

Liraglutide reduces body weight by upregulation of adenylate cyclase 3
por: Li, Z, et al.
Publicado: (2017)

Degree of obesity and gastrointestinal adverse reactions influence the weight loss effect of liraglutide in overweight or obese patients with type 2 diabetes
por: Zhou, Fang, et al.
Publicado: (2023)

Glucagon-like peptide-1 receptor activation stimulates PKA-mediated phosphorylation of Raptor and this contributes to the weight loss effect of liraglutide
por: Le, Thao DV, et al.
Publicado: (2023)

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
por: Astrup, A, et al.
Publicado: (2012)

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analogue, liraglutide
por: Astrup, A, et al.
Publicado: (2012)

SUN-694 Case Study of Nonalcoholic Steatohepatitis Reversibility in Type Two Diabetic Patient with Weight Loss Using Liraglutide
por: Shaghouli, Amna Ali, et al.
Publicado: (2020)

Energy intake as a short‐term biomarker for weight loss in adults with obesity receiving liraglutide: A randomized trial
por: Saxena, Aditi R., et al.
Publicado: (2021)

Diabetic Retinopathy and Hearing Loss: Results from the Fifth Korean National Health and Nutrition Survey
por: Shin, Yong Un, et al.
Publicado: (2021)

Efficacy and Safety of the New Appetite Suppressant, Liraglutide: A Meta-Analysis of Randomized Controlled Trials
por: Moon, Shinje, et al.
Publicado: (2021)

The Frequency and Causes of Not-Detected Breast Malignancy in Dynamic Contrast-Enhanced MRI
por: Song, Donghun, et al.
Publicado: (2022)

Oxidative stress-mediated TXNIP loss causes RPE dysfunction
por: Ji Cho, Min, et al.
Publicado: (2019)

A Case of Otogenic Brain Abscess Causing Loss of Consciousness
por: Kwak, Min Kyu, et al.
Publicado: (2014)

A Novel ‘Bailout Switch Crush Technique’ for a Jailed Side Branch Unable to Rewire
por: Roh, Jae-Hyung, et al.
Publicado: (2021)

Response: Differences in Clinical Outcomes between Patients with and without Hypoglycemia during Hospitalization: A Retrospective Study Using Real-World Evidence (Diabetes Metab J 2020;44:555-65)
por: Lee, Jeongmin, et al.
Publicado: (2020)

Risk factors deteriorating severe exocrine pancreatic insufficiency measured by stool elastase after pancreatoduodenectomy and the risk factors for weight loss
por: Cho, Ara, et al.
Publicado: (2022)

Hippocampal Lesions of Diffusion Weighted Magnetic Resonance Image in Patients with Headache without Symptoms of Transient Global Amnesia
por: Park, Jeong Hoon, et al.
Publicado: (2017)

Cardiovascular Risk Reduction in Type 2 Diabetes: Further Insights into the Power of Weight Loss and Exercise
por: Lee, Seung-Hwan
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6bumq0t14tv3bm5pgmhmecc5ri